Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Axsome Therapeutics (AXSM) Long-Term Debt Issuances (2023 - 2025)

Axsome Therapeutics' Long-Term Debt Issuances history spans 2 years, with the latest figure at $70.0 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to $70.0 million; the TTM value through Dec 2025 reached $140.0 million, changed N/A, while the annual FY2025 figure was $330.0 million, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q4 2025 was $70.0 million at Axsome Therapeutics, roughly flat from $70.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $70.0 million in Q3 2025 and bottomed at $30.0 million in Q2 2023.